Federal Register - August 2, 2021

Version en texte Qu'est-ce que c'est?Dateas est un site Web indépendant, non affilié à un organisme gouvernemental. La source des documents PDF que nous publions est l'agence officielle indiquée dans chacun d'eux. Les versions en texte sont des transcriptions non officielles que nous faisons pour fournir de meilleurs outils d'accès et de recherche d'informations, mais peuvent contenir des erreurs ou peuvent ne pas être complètes.

Source: Federal Register

41494

Federal Register / Vol. 86, No. 145 / Monday, August 2, 2021 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health Services Administration Agency Information Collection Activities: Proposed Collection;
Comment Request In compliance with Section 3506c2A of the Paperwork Reduction Act of 1995 concerning opportunity for public comment on proposed collections of information, the Substance Abuse and Mental Health Services Administration SAMHSA
will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the information collection plans, call the SAMHSA
Reports Clearance Officer on 240 276
0361.
Comments are invited on: a Whether the proposed collections of information are necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility;
b the accuracy of the agencys estimate of the burden of the proposed collection of information; c ways to enhance the quality, utility, and clarity of the information to be collected; and d ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology.

Proposed Project: Opioid Drugs in Maintenance and Detoxification Treatment of Opioid Dependence42
CFR Part 8 OMB No. 09300206 and Opioid Treatment Programs OTPs Extension 42 CFR part 8 establishes a certification program managed by SAMHSAs Center for Substance Abuse Treatment CSAT. The regulation requires that Opioid Treatment Programs OTPs be certified.
Certification is the process by which SAMHSA determines that an OTP is qualified to provide opioid treatment under the Federal opioid treatment standards established by the Secretary of Health and Human Services. To become certified, an OTP must be accredited by a SAMHSA-approved accreditation body. The regulation also provides standards for such services as individualized treatment planning, increased medical supervision, and assessment of patient outcomes. This submission seeks continued approval of the information collection requirements in the regulation and of the forms used in implementing the regulation.
SAMHSA currently has approval for the Application for Certification to Use Opioid Drugs in a Treatment Program Under 42 CFR 8.11 Form SMA162;
the Application for Approval as Accreditation Body Under 42 CFR 8.3b Form SMA163; and the Exception Request and Record of Justification Under 42 CFR 8.12 Form SMA168, Number of respondents
Form
Responses/
respondent
which may be used on a voluntary basis by physicians when there is a patient care situation in which the physician must make a treatment decision that differs from the treatment regimen required by the regulation. Form SMA
168 is a simplified, standardized form to facilitate the documentation, request, and approval process for exceptions.
SAMHSA believes that the recordkeeping requirements in the regulation are customary and usual practices within the medical and rehabilitative communities and has not calculated a response burden for them.
The recordkeeping requirements set forth in 42 CFR 8.4, 8.11 and 8.12
include maintenance of the following: 5year retention by accreditation bodies of certain records pertaining to accreditation; documentation by an OTP
of the following: A patients medical examination when admitted to treatment, A patients history, a treatment plan, any prenatal support provided the patient, justification of unusually large initial doses, changes in a patients dosage schedule, justification of unusually large daily doses, the rationale for decreasing a patients clinic attendance, and documentation of physiologic dependence.
The tables that follows summarizes the annual reporting burden associated with the regulation, including burden associated with the forms. There are no changes being made to the forms.
Total responses
Hours/
response
Total hours
Estimated Annual Reporting Requirement Burden for Accreditation Bodies SMA163

54

26.055

1,407

0.28

394

khammond on DSKJM1Z7X2PROD with NOTICES

Estimated Annual Reporting Requirement Burden for Opioid Treatment Programs SMA162
SMA168

651.33
1,302.67

17.976
17.977

11,708.91
23,418.09

Subtotal

1,954

17.977

35,127

0.08

2,902

Total

36,534

3,296

Send comments to Carlos Graham, SAMHSA Reports Clearance Officer, Room 15E57A, 5600 Fishers Lane, Rockville, MD 20850 OR email him a
copy at carlos.graham@samhsa.hhs.gov.

Written comments should be received within 60 days of this notice.
Carlos Graham, Statistician.
FR Doc. 202116402 Filed 73021; 8:45 am BILLING CODE 416220P

VerDate Sep<11>2014

17:21 Jul 30, 2021

Jkt 253001

PO 00000

Frm 00062

Fmt 4703

Sfmt 4703

E:FRFM02AUN1.SGM

02AUN1

Acerca de esta edición

Federal Register - August 2, 2021

TitreFederal Register

PaysÉtats-Unis

Date02/08/2021

Page count328

Edition count7802

Première édition14/03/1936

Dernière édition25/06/2026

Télécharger cette édition

Otras ediciones

<<<Agosto 2021>>>
DLMMJVS
1234567
891011121314
15161718192021
22232425262728
293031